97 related articles for article (PubMed ID: 24137971)
41. Influence of mucolytic therapy on respiratory mechanics in patients with chronic obstructive pulmonary disease.
Schreiber J; Bohnsteen B; Rosahl W
Eur J Med Res; 2002 Mar; 7(3):98-102. PubMed ID: 11953279
[TBL] [Abstract][Full Text] [Related]
42. [A coughing patients makes a visit to the otorhinolaryngologist's office: the practical aspects of diagnostics and treatment].
Nosulya EV
Vestn Otorinolaringol; 2016; 81(3):57-60. PubMed ID: 27367353
[TBL] [Abstract][Full Text] [Related]
43. Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment.
Glattki GP; Manika K; Sichletidis L; Alexe G; Brenke R; Spyratos D
Am J Clin Oncol; 2012 Apr; 35(2):120-5. PubMed ID: 21378541
[TBL] [Abstract][Full Text] [Related]
44. [Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease].
Tsvetkova OA; Veselovskaia MV
Ter Arkh; 2007; 79(3):25-9. PubMed ID: 17526191
[TBL] [Abstract][Full Text] [Related]
45. [The role of endothelial dysfunction in the pathogenesis of combined cardiopulmonary diseases].
Zarubina EG; Mishina EA; Osadchuk MA
Klin Med (Mosk); 2006; 84(5):31-4. PubMed ID: 16827275
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of itraconazole in the treatment of patients with chronic cough whose sputa yield basidiomycetous fungi-fungus-associated chronic cough (FACC).
Ogawa H; Fujimura M; Takeuchi Y; Makimura K
J Asthma; 2009 May; 46(4):407-12. PubMed ID: 19484679
[TBL] [Abstract][Full Text] [Related]
47. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.
Lindberg A; Lundbäck B
Clin Respir J; 2008 Oct; 2 Suppl 1():64-71. PubMed ID: 20298352
[TBL] [Abstract][Full Text] [Related]
48. [Comorbidity in chronic obstructive pulmonary disease].
Karoli NA; Orlova EE; Markova AV; Rebrov AP
Ter Arkh; 2008; 80(3):20-3. PubMed ID: 18441678
[TBL] [Abstract][Full Text] [Related]
49. Modified Charlson comorbidity index for predicting survival after liver transplantation.
Volk ML; Hernandez JC; Lok AS; Marrero JA
Liver Transpl; 2007 Nov; 13(11):1515-20. PubMed ID: 17969207
[TBL] [Abstract][Full Text] [Related]
50. [Relationship between SGRQ score and pulmonary function and its influencing factors in patients with chronic obstructive pulmonary disease].
Liu R; DU YP; He B
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1533-7. PubMed ID: 21914365
[TBL] [Abstract][Full Text] [Related]
51. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation.
Cydulka RK; Rowe BH; Clark S; Emerman CL; Rimm AR; Camargo CA
Acad Emerg Med; 2005 Dec; 12(12):1173-9. PubMed ID: 16282511
[TBL] [Abstract][Full Text] [Related]
52. [Evaluation of clinical effectiveness and direct costs of azithromycin treatment for exacerbation of chronic obstructive pulmonary disease in hospitalized patients and ambulatory care].
Faber M; Jahnz-Rózyk K; Kucharczyk A; Targowski T; From S; Mamełka B
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():96-9. PubMed ID: 15524029
[TBL] [Abstract][Full Text] [Related]
53. [Chronic obstructive pulmonary disease patients in the general practice].
Siatkowska H; Kozielski J; Ziora D
Pneumonol Alergol Pol; 2010; 78(2):112-20. PubMed ID: 20306422
[TBL] [Abstract][Full Text] [Related]
54. Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass.
Ulas MM; Hizarci M; Kunt A; Ergun K; Kocabeyoglu SS; Korkmaz K; Lafci G; Gedik S; Cagli K
J Cardiovasc Pharmacol; 2008 Dec; 52(6):518-23. PubMed ID: 19034033
[TBL] [Abstract][Full Text] [Related]
55. [Efficacy of a complementary antiinflammatory treatment with erespal in chronic obstructive and nonobstructive bronchitis].
Volkova LI; Budkova AA; Filonova NN; Khristoliubova EI; Kutuzova EB; Koroleva NV; Radzivil TT; Aminova ZR; Chuchalin AG
Ter Arkh; 2004; 76(8):51-6. PubMed ID: 15471398
[TBL] [Abstract][Full Text] [Related]
56. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.
Rennard SI; Fogarty C; Kelsen S; Long W; Ramsdell J; Allison J; Mahler D; Saadeh C; Siler T; Snell P; Korenblat P; Smith W; Kaye M; Mandel M; Andrews C; Prabhu R; Donohue JF; Watt R; Lo KH; Schlenker-Herceg R; Barnathan ES; Murray J;
Am J Respir Crit Care Med; 2007 May; 175(9):926-34. PubMed ID: 17290043
[TBL] [Abstract][Full Text] [Related]
57. Optimization of pathogenetic therapy in patients with chronic obstructive lung disease.
Potyazhenko MM; Ishcheikin KY; Nastroga TV; Sokolyuk NL; Kitura OY; Gorodnytska IM
Wiad Lek; 2020; 73(4):773-776. PubMed ID: 32731714
[TBL] [Abstract][Full Text] [Related]
58. Cough Suppressant and Fluoxetine in the Treatment of Pseudobulbar Affect: A Case Report.
Butler MI; Williams D; Cotter DR
J Clin Psychopharmacol; 2016 Oct; 36(5):525-6. PubMed ID: 27496344
[No Abstract] [Full Text] [Related]
59. [Chronic obstructive pulmonary disease and comorbidities].
Chuchalin AG
Ter Arkh; 2013; 85(8):43-8. PubMed ID: 24137963
[TBL] [Abstract][Full Text] [Related]
60. [Exploration on mechanism of Chinese medical recipe for cough-remedy and sputum-removing].
Miyata T; Isohama Y; Kai H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Aug; 18(8):502-3. PubMed ID: 11477836
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
